Abstract:Background and Objectives: Wolfram syndrome type 1 (OMIM# 222300; ORPHAcode 3463) is an extremely rare autosomal recessive syndrome with a 25% recurrence risk in children. It is characterized by the presence of juvenile-onset diabetes mellitus (DM), progressive optic atrophy (OA), diabetes insipidus (DI), and sensorineural deafness (D), often referred to by the acronym DIDMOAD. It is a severe neurodegenerative disease with a life expectancy of 39 years, with death occurring due to cerebral atrophy. For a positive diagnosis, the presence of diabetes mellitus and optic nerve atrophy is sufficient. The disease occurs because of pathogenic variants in the WFS1 gene. The aim of this article is to present a case report of Wolfram Syndrome Type I, alongside a review of genetic variants, clinical manifestations, diagnosis, therapy, and long-term management. Emphasizing the importance of early diagnosis and a multidisciplinary approach, the study aims to enhance understanding and improve outcomes for patients with this complex syndrome. Materials and Methods: A case of a 28-year-old patient diagnosed with DM at the age of 6 and with progressive optic atrophy at 26 years old is presented. Molecular diagnosis revealed the presence of a heterozygous nonsense variant WFS1 c.1943G>A (p.Trp648*), and a heterozygous missense variant WFS1 c.1675G>C (p.Ala559Pro). Results: The molecular diagnosis of the patient confirmed the presence of a heterozygous nonsense variant and a heterozygous missense variant in the WFS1 gene, correlating with the clinical presentation of Wolfram syndrome type 1. Both allelic variants found in our patient have been previously described in other patients, whilst this combination has not been described before. Conclusions: This case report and review underscores the critical role of early recognition and diagnosis in Wolfram syndrome, facilitated by genetic testing. By identifying pathogenic variants in the WFS1 gene, genetic testing not only confirms diagnosis but also guides clinical management and informs genetic counseling for affected families. Timely intervention based on genetic insights can potentially reduce the progressive multisystem manifestations of the syndrome, thereby improving the quality of life and outcomes for patients.

Sequential Presentation of Obsessive-Compulsive Disorder and Narcolepsy in a 10-Year-Old Girl With Wolfram Syndrome 1

An adolescent with Wolfram syndrome and central sleep apnea

Wolfram Syndrome Type I Case Report and Review-Focus on Early Diagnosis and Genetic Variants

OBSESSIVE COMPULSIVE DISORDER AND CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY IN WOLFRAM SYNDROME: NEW ASPECTS AND A NOVEL WFS1 MUTATION

Psychiatric Diagnoses and Medications in Wolfram Syndrome

Wolfram Syndrome 1: A Neuropsychiatric Perspective on a Rare Disease

The Novel Compound Heterozygous Mutations, V434del and W666X, in WFS1 Gene Causing the Wolfram Syndrome in a Chinese Family

Wolfram syndrome type 1: a case series

Phenotypic characteristics of early Wolfram syndrome

Early presentation of urological abnormalities in a case of Wolfram syndrome

Beyond Vision and Hearing: A Case Report of Wolfram Syndrome

Long term clinical follow up of four patients with Wolfram syndrome and urodynamic abnormalities

A Wolfram-like syndrome family: Case report

A Novel Mutation of WFS1 Gene in a Chinese Patient with Wolfram Syndrome: a Case Report

Beyond Wolfram Syndrome 1: The WFS1 Gene's Role in Alzheimer's Disease and Sleep Disorders

Neuroimaging features in Wolfram syndrome type 1

[Wolfram-like syndrome: a case report]

Insights from a Wolfram syndrome cohort: clinical and molecular findings from a specialized diabetes reference center

Sleep disturbances correlate with behavioral problems among individuals with Wiedemann-Steiner syndrome

A Novel Mutation of WFS1 Gene Leading to Increase ER Stress and Cell Apoptosis is Associated an Autosomal Dominant Form of Wolfram Syndrome Type 1

Clinical Analysis of One Case of Wolfram Syndrome Caused by Atypical Genetic Mutations and Literature Review